Additional treatment of a refluxing saphenous trunk in SAP group at 9 months
Of all 227 patients in the SAP group, 58 (25.6 per cent) received additional truncal treatment after 9 months, either by EVLA, UGFS or radiofrequency ablation with VNUS ClosureFAST. The additional treatment was not specified for one patient. No additional truncal treatment was required in 167 patients (73.5 per cent) (Additional treatments of great saphenous vein and anterior accessory saphenous vein in isolated ambulatory phlebectomy with or without delayed endovenous truncal ablation groupValues are 